ASSOCIATION OF ABC POLYMORPHISM WITH ANTIEMETIC EFFICACY IN CANCER PATIENTS TREATED WITH HIGHLY EMETOGENIC CHEMOTHERAPY

被引:0
|
作者
Tsuji, Daiki [1 ]
Kim, Yong-Il [2 ]
Daimon, Takashi [3 ]
Makuta, Ryo [1 ]
Homma, Chiho [2 ]
Nakamichi, Hidenori [4 ]
Yamamoto, Keisuke [4 ]
Hayashi, Hideki [1 ]
Inoue, Kazuyuki [1 ]
Itoh, Kunihiko [1 ]
机构
[1] Univ Shizuoka, Dept Clin Pharmacol & Genet, Shizuoka 4228526, Japan
[2] Seirei Hamamatsu Gen Hosp, Dept Med Oncol, Hamamatsu, Shizuoka, Japan
[3] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo, Japan
[4] Seirei Hamamatsu Gen Hosp, Dept Pharm, Hamamatsu, Shizuoka, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1-26-1
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Quality of life, efficacy, and patient-reported outcome with NEPA as antiemetic prophylaxis in patients receiving highly or moderately emetogenic chemotherapy
    Karthaus, M.
    Rauh, J.
    Guth, D.
    Heilmann, V.
    Schilling, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [22] PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY
    BALLATORI, E
    ROILA, F
    DEANGELIS, V
    TONATO, M
    RIVA, E
    BARBIERI, P
    DELFAVERO, A
    BASURTO, C
    CICCARESE, G
    PALLADINO, MA
    MOSCONI, AM
    ANASTASI, P
    PICCIAFUOCO, M
    CAMPORA, E
    CHIARA, S
    COGNETTI, F
    FERRARESI, V
    FABI, A
    COLELLA, E
    CIRULLI, S
    SABBATINI, R
    FEDERICO, M
    BARBIERI, F
    SILINGARDI, V
    ANNA, S
    DONATI, D
    MAESTRI, A
    MALACARNE, P
    RICCI, S
    ANTONUZZO, A
    CONTE, PF
    SALVATI, F
    NUNZIATI, F
    ANTILLI, A
    CATALANO, G
    CASCINU, S
    DICOSTANZO, F
    TAGLIAVENTI, M
    ZANIBONI, Z
    MERIGGI, F
    CORTESI, E
    CALABRO, F
    CARLO, S
    LUPORINI, G
    DANTONA, A
    SANTORO, A
    GIACOBONE, A
    MANTELLINI, E
    FERRETTI, G
    BONI, C
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) : 2417 - 2426
  • [23] THE EFFICACY OF TRIPLET ANTIEMETIC THERAPY FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN LUNG CANCER PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY: PALONOSETRON (PALO), APREPITANT (APR), AND DEXAMETHASONE (DEX)
    Yoshizawa, H.
    Sato, K.
    Makino, M.
    Kobayashi, O.
    Tanaka, H.
    Miura, S.
    Watanabe, S.
    Tanaka, J.
    Kagamu, H.
    Ichiei, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 509 - 509
  • [24] Efficacy of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A network meta-analysis
    Filetti, M.
    Lombardi, P.
    Falcone, R.
    Giannarelli, D.
    Carcagni, A.
    Giusti, R.
    Scambia, G.
    Daniele, G.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1266 - S1266
  • [25] Antiemetic recommendations for breast cancer patients receiving highly emetogenic chemotherapy: A systematic review incorporating network meta-analyses
    Ng, Terry L.
    Hutton, Brian
    Kuchuk, Iryna
    Roscoe, Joseph A.
    Mazzarello, Sasha
    Clemons, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Efficacy of NEPA as antiemetic prophylaxis in breast cancer patients receiving highly or moderately emetogenic chemotherapy - Interim results of a German prospective, non-interventional study
    Schilling, J.
    Hielscher, C.
    Hanusch, C.
    Kurbacher, C.
    Busch, S.
    Karthaus, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [27] Omission of dexamethasone from antiemetic treatment for highly emetogenic chemotherapy in breast cancer patients with hepatitis B infection or diabetes mellitus
    Nakayama, Yoshie
    Ito, Yoshinori
    Tanabe, Masahiko
    Takahashi, Shunji
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2016, 14 (05): : 210 - 214
  • [28] Evaluation of efficacy of new antiemetic regimen containing aprepitant plus granisetron (without dexamethasone) vs standard antiemetic regimen in highly emetogenic chemotherapy
    Abramov, M.
    Polushkina, I.
    Lichinitser, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 188 - 188
  • [29] ANTIEMETIC EFFICACY OF PALONOSETRON IN CHILDREN RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY: PRELIMINARY RESULTS
    Varrasso, G.
    De Grazia, A.
    Mollace, M. G.
    Megaro, G.
    Paiano, M.
    Suraci, S.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 174 - 174
  • [30] ANTIEMETIC EFFICACY OF CIMETIDINE RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY WITH DEXAMETHASONE IN CANCER-PATIENTS RECEIVING EMETOGENIC CHEMOTHERAPY
    ALGHAMDI, MS
    IBRAHIM, EM
    ALIDRISSI, HY
    ALKHATTI, AA
    ALFARAJ, A
    ANNALS OF ONCOLOGY, 1991, 2 (07) : 517 - 518